Plakophilin-2

Structure

Two splice variants of the PKP2 gene have been identified. The first has a molecular weight of 97.4 kDa (881 amino acids) and the second of molecular weight of 92.7 kDa (837 amino acids). A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13.

Plakophilin-2 is a member of the armadillo repeat and plakophilin protein family. Plakophilin proteins contain nine central, conserved armadillo repeat domains flanked by N-terminal and C-terminal domains. Alternately spliced transcripts encoding protein isoforms have been identified.

Plakophilin 2 localizes to cell desmosomes and nuclei and binds plakoglobin, desmoplakin, and the desmosomal cadherins via N-terminal head domain.

Function

Plakophilin 2 functions to link cadherins to intermediate filaments in the cytoskeleton. In cardiomyocytes, plakophilin-2 is found at desmosome structures within intercalated discs, which link adjacent sarcolemmal membranes together. The desmosomal protein, desmoplakin, is the core constituent of the plaque which anchors intermediate filaments to the sarcolemma by its C-terminus and indirectly to sarcolemmal cadherins by its N-terminus, facilitated by plakoglobin and plakophilin-2. Plakophilin is necessary for normal localization and content of desmoplakin to desmosomes, which may in part be due to the recruitment of protein kinase C alpha to desmoplakin.

Ablation of PKP2 in mice severely disrupts normal heart morphogenesis. Mutant mice are embryonic lethal and exhibit deficits in the formation of adhering junctions in cardiomyocytes, including the dissociation of desmoplakin and formation of cytoplasmic granular aggregates around embryonic day 10.5-11. Additional malformation included reduced trabeculation, cytoskeletal disarray and cardiac wall rupture. Further studies demonstrated that plakophilin-2 coordinate with E-cadherin is required to properly localize RhoA early in actin cytoskeletal rearrangement in order to properly couple the assembly of adherens junctions to the translocation of desmosome precursors in newly formed cell-cell junctions.

Plakophilin-2 over time has shown to be more than components of cell-cell junctions; rather the plakophilins are emerging as versatile scaffolds for various signaling pathways that more globally modulate diverse cellular activities. Plakophilin-2 has shown to localize to nuclei, in addition to desmosomal plaques in the cytoplasm. Studies have shown that plakkophillin-2 is found in the nucleoplasm, complexed in the RNA polymerase III holoenzyme with the largest subunit of RNA polymerase III, termed RPC155.

There are data to support molecular crosstalk between plakophilin-2 and proteins involved in mechanical junctions in cardiomyocytes, including connexin 43, the major component of cardiac gap junctions; the voltage-gated sodium channel Na(V)1.5 and its interacting subunit, ankyrin G; and the K(ATP). Decreased expression of plakophilin-2 via siRNA leads to a decrease in and redistribution of connexin 43 protein, as well as a decrease in coupling of adjacent cardiomyocytes. Studies also showed that GJA1 and plakophilin-2 are components in the same biomolecular complex. Plakophilin-2 also associates with Na(V)1.5, and knockdown of plakophilin-2 in cardiomyocytes alters sodium current properties as well as velocity of action potential propagation. It has also been demonstrated that plakophilin-2 associates with an important component of the Na(V)1.5 complex, ankyrin G, and loss of ankyrin G via siRNA downregulation mislocalized plakophilin-2 and connexin 43 in cardiac cells, which was coordinate with decreased electrical coupling of cells and decreased adhesion strength. These studies were further supported by an investigation in a mouse model harboring a PKP2-heterozygous null mutation, which showed decreased Na(V)1.5 amplitude, as well as a shift in gating and kinetics; pharmacological challenge also induced ventricular arrhythmias. These findings further support the notion that desmosomes crosstalk with sodium channels in the heart, and suggest that the risk of arrhythmias in patients with PKP2 mutations may be unveiled with pharmacological challenge. Evidence has also shown that plakophilin-2 binds to the K(ATP) channel subunit, Kir6.2, and that in cardiomyocytes from haploinsufficient PKP2 mice, K(ATP) channel current density was ~40% smaller and regional heterogeneity of K(ATP) channels was altered, suggesting that plakophilin-2 interacts with K(ATP) and mediates crosstalk between intercellular junctions and membrane excitability.

Clinical significance

Mutations in PKP2 have been associated with, have been shown to cause, and are considered common in arrhythmogenic right ventricular cardiomyopathy, which is characterized by fibrofatty replacement of cardiomyocytes, ventricular tachycardia and sudden cardiac death. It is estimated that 70% of all mutations associated with arrhythmogenic right ventricular cardiomyopathy are within the PKP2 gene. These mutations in general appear to disrupt the assembly and stability of desmosomes. Mechanistic studies have shown that certain PKP2 mutations result in instability of the plakophilin-2 protein due to enhanced calpain-mediated degradation.

Specific and sensitive markers of PKP2 and plakoglobin mutation carriers in arrhythmogenic right ventricular cardiomyopathy have been identified to include T-wave inversions, right ventricular wall motion abnormalities, and ventricular extrasystoles. Additionally, immunohistochemical analysis of proteins comprising cardiomyocyte desmosomes has shown to be a highly sensitive and specific diagnostic indicator.

Clinical and genetic characterization of arrhythmogenic right ventricular cardiomyopathy is currently under intense investigation to understand the penetrance associated with PKP2 mutations, as well as other genes encoding desmosomal proteins, in disease progression and outcome.

PKP2 mutations were also found to coexist with sodium channelopathies in patients with Brugada syndrome.

Additionally, plakophilin-2 was found in adherens junctions of cardiac myxomata tumors analyzed, and absent in patients with noncardiac myxomata, suggesting that plakophilin-2 may serve as a valuable marker in the clinical diagnosis of cardiac myxomata.

Interactions

PKP2 has been shown to interact with:

• ankyrin G,
• beta catenin,
• desmocollin 1,
• desmocollin 2,
• desmoglein 1,
• desmoglein 2,
• desmoplakin,
• connexin 43,
• plakoglobin,
• Kir6.2, and
• SCN5A.

References

References

1. (Jan 1997). "Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque". J Cell Biol.
2. "Entrez Gene: PKP2 plakophilin 2".
3. "Protein sequence of human PKP2 (Uniprot ID: Q99959)".
4. "Protein sequence of human PKP2 (Uniprot ID: Q99959-2)".
5. (October 2009). "Plakophilins: multifunctional scaffolds for adhesion and signaling". Current Opinion in Cell Biology.
6. (November 2014). "Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy". Heart Rhythm.
7. (March 2002). "Protein binding and functional characterization of plakophilin 2. Evidence for its diverse roles in desmosomes and beta -catenin signaling". The Journal of Biological Chemistry.
8. (July 2001). "Nuclear particles containing RNA polymerase III complexes associated with the junctional plaque protein plakophilin 2". Proceedings of the National Academy of Sciences of the United States of America.
9. (March 2008). "Desmosome structure, composition and function". Biochimica et Biophysica Acta (BBA) - Biomembranes.
10. (July 2004). "Plakins: goliaths that link cell junctions and the cytoskeleton". Nature Reviews Molecular Cell Biology.
11. (May 2008). "Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly". The Journal of Cell Biology.
12. (October 2004). "Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation". The Journal of Cell Biology.
13. (August 2010). "Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA". Molecular Biology of the Cell.
14. (September 2007). "Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells". Circulation Research.
15. (September 2009). "Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes". Circulation Research.
16. (July 2011). "Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc". Circulation Research.
17. (September 2012). "Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency". Cardiovascular Research.
18. (November 2012). "Heterogeneity of ATP-sensitive K+ channels in cardiac myocytes: enrichment at the intercalated disk". The Journal of Biological Chemistry.
19. (April 2015). "Comprehensive analysis of desmosomal gene mutations in Han Chinese patients with arrhythmogenic right ventricular cardiomyopathy". European Journal of Medical Genetics.
20. (November 2013). "Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy". European Journal of Human Genetics.
21. (2012). "PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA)". Circulation Journal.
22. (December 2010). "Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia". Netherlands Heart Journal.
23. (November 2004). "Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy". Nature Genetics.
24. (Jan 2006). "Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy". Circulation.
25. (August 2006). "Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family". Heart Rhythm.
26. (May 2008). "Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy". International Journal of Cardiology.
27. (April 2006). "Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy". Circulation.
28. (2009). "Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability". Cell Communication & Adhesion.
29. (August 2012). "Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations". Circulation: Cardiovascular Genetics.
30. (September 2006). "Arrhythmogenic right ventricular cardiomyopathy caused by deletions in plakophilin-2 and plakoglobin (Naxos disease) in families from Greece and Cyprus: genotype-phenotype relations, diagnostic features and prognosis". European Heart Journal.
31. (July 2009). "Cardiomyopathies: New test for arrhythmogenic right ventricular cardiomyopathy". Nature Reviews. Cardiology.
32. (June 2011). "Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study". Circulation.
33. (August 2011). "Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy". Heart Rhythm.
34. (April 2007). "Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression". Circulation.
35. (May 2007). "Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?". Current Opinion in Cardiology.
36. (May 2008). "Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy". Nature Clinical Practice Cardiovascular Medicine.
37. (October 2009). "Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy". Circulation: Cardiovascular Genetics.
38. (Jan 2010). "Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia". Heart Rhythm.
39. (June 2010). "Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice". Europace.
40. (June 2014). "Skin-heart connection: what can the epidermis tell us about the myocardium in arrhythmogenic cardiomyopathy?". Circulation: Cardiovascular Genetics.
41. (October 2014). "Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy". Journal of Medical Genetics.
42. (March 2014). "Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype". Circulation.
43. (July 2014). "Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome". Trends in Cardiovascular Medicine.
44. (November 2010). "A novel kind of tumor type-characteristic junction: plakophilin-2 as a major protein of adherens junctions in cardiac myxomata". Modern Pathology.
45. (November 2013). "Super-resolution fluorescence microscopy of the cardiac connexome reveals plakophilin-2 inside the connexin43 plaque". Cardiovascular Research.